Recent Quotes (30 days)

You have no recent quotes
chg | %

Medmira Inc  

(Public, CVE:MIR)   Watch this stock  
Find more results for MIR
0.0000 (0.00%)
Dec 18 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.05 - 0.05
52 week 0.05 - 0.14
Open 0.05
Vol / Avg. 51,000.00/73,365.00
Mkt cap 26.82M
P/E     -
Div/yield     -
EPS -0.01
Shares 536.36M
Beta 0.12
Inst. own     -
Nov 28, 2014
Q4 2014 MedMira Inc Earnings Release

Key stats and ratios

Q3 (Jul '14) 2014
Net profit margin -40.17% -151.70%
Operating margin -91.68% -141.15%
EBITD margin - -137.86%
Return on average assets -79.80% -254.94%
Return on average equity - -
Employees 65 -
CDP Score - -


Suite 1, 155 Chain Lake Dr
+1-902-4501588 (Phone)
+1-902-4501580 (Fax)

Website links


MedMira Inc.( MedMira) is a biotechnology company. The Company is engaged in the development and commercialization of diagnostics and technology platforms. The Company operates in North America, Latin America/Caribbean, Europe and Asia Pacific. It invests in research. The Company�s tests provide hospitals, labs, clinics and individuals with instant diagnosis for diseases, such as HIV and hepatitis C in just three steps. The Company�s tests are sold under the Reveal, Multiplo and Miriad brands. The Company sells its tests through a worldwide network of medical distributors and strategic business development partners with customers in all sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies.

Officers and directors

Hermes Chan Chief Executive Officer, Director
Markus M. Meile Chief Financial Officer, Director
Sing Chan Chief Operating Officer
Robyn Cook Chief Corporate Officer, Corporate Secretary
Marvyn Robar Non-Executive Chairman of the Board
Colin MacGillivray Director
Michael Sidler Director
Romano Robusto Independent Director